Lakefront Biotherapeutics (GXEA) Q2 2024 Earnings Report
DE:GXEA Q2 2024 EPS Results
- Actual EPS
- EUR 0.07
- Consensus EPS
- -EUR 0.07
- Beat/Miss
- Beat by +EUR 0.14
- One Year Ago EPS
- EUR 0.08
DE:GXEA Q2 2024 Revenue Results
- Actual Revenue
- EUR 74.96M
- Expected Revenue
- EUR 61.55M
- Beat/Miss
- Beat by +EUR 13.41M
- YoY Revenue Growth
- -48.63%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- After Close
- Conference Call
- Thursday, August 1, 2024
DE:GXEA Upcoming Earnings
Lakefront Biotherapeutics's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:GXEA Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GXEA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | -0.74- | -3.17 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -0.740.03 | -1.66 | 101.83% (+1.69) | |
| May 06, 2026 | 2026 (Q1) | -0.840.22 | -2.39 | 109.24% (+2.61) | |
| Feb 23, 2026 | 2025 (Q4) | -0.1112.43 | 0.27 | 4502.65% (+12.16) | |
| Nov 05, 2025 | 2025 (Q3) | -0.43-3.17 | -0.72 | -341.22% (-2.45) | |
| Jul 23, 2025 | 2025 (Q2) | -0.20-1.66 | 0.07 | -2475.64% (-1.73) | |
| Apr 23, 2025 | 2025 (Q1) | -0.13-2.39 | 0.35 | -788.92% (-2.74) | |
| Feb 12, 2025 | 2024 (Q4) | -0.490.27 | 2.31 | -88.32% (-2.04) | |
| Oct 30, 2024 | 2024 (Q3) | -0.15-0.72 | 0.37 | -291.65% (-1.09) | |
| Aug 01, 2024 | 2024 (Q2) | -0.070.07 | 0.08 | -11.36% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
